A Trial to Assess Efficacy, Safety, Pharmacokinetics of Octreotide Subcutaneous Injection in Patients With Gastroentero-pancreatic Neuroendocrine Tumor (GEP-NET)
Clinical trial NCT06505395 · RECRUITING
Trial details
- NCT number
- NCT06505395
- Sponsor
- CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-30
- Primary completion
- 2027-08-01
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.